Form D — Iaso Therapeutics, Inc.
0000905729-26-000020 · filed 2026-01-14
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $1,800,000
- Total sold
- $570,000
- Minimum investment
- $25,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Iaso Therapeutics, Inc.
- CIK
- 1961165
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4942 DAWN AVE
EAST LANSING, MI 48823 - Phone
- 773-437-0274
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Forgey · Executive OfficerEAST LANSING, MI Find on LinkedIn ↗
-
Xuefei Huang · Executive OfficerEast Lansing, MI Find on LinkedIn ↗
-
Steve Kuemmerie · DirectorEast Lansing, MI Find on LinkedIn ↗
-
Jeffrey Wesley · DirectorEast Lansing, MI Find on LinkedIn ↗
-
Donald Parfet · DirectorEast Lansing, MI Find on LinkedIn ↗
View original on SEC EDGAR.